Drug interactions with methadone: Time to revise the product label.

Abstract

Methadone was first approved for clinical use in the United States in 1972. It is currently indicated for the treatment of moderate to severe pain, for detoxification of opiate addiction, and for maintenance treatment of individuals with opiate dependence. Because of concerns about methadone-associated respiratory depression as well as prolongation of the… (More)
DOI: 10.1002/cpdd.137

Topics

Cite this paper

@article{Greenblatt2014DrugIW, title={Drug interactions with methadone: Time to revise the product label.}, author={David J Greenblatt}, journal={Clinical pharmacology in drug development}, year={2014}, volume={3 4}, pages={249-51} }